Boothbay Fund Management »

4d Molecular Therapeutics In shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 150k 31.86

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dell Technologies CL C Call Option (DELL)
Select Sector Spdr Tr Indl Put Option (XLI)
Cornerstone Strategic Value (CLM)
NVIDIA Corporation Put Option (NVDA)
Take-Two Interactive Software (TTWO)
Sba Communications Corp Cl A (SBAC)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Netflix (NFLX)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Elanco Animal Health Call Option (ELAN)
Amphenol Corp Cl A (APH)
Western Digital Call Option (WDC)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Equinix (EQIX)

View all positions for Boothbay Fund Management

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
VR Adviser
Deep Track Capital
Goldman Sachs Group
Henderson Group
Vanguard Group
State Street Corporation
Novo A/S
Redmile Group
Braidwell
Casdin Capital
Geode Capital Management
Polar Capital Holdings

View all funds holding 4d Molecular Therapeutics In